Sanofi's Chew on Auvi-Q Voice-Guided Injector

Aug. 15 (Bloomberg) -- Paul Chew, chief science officer for Sanofi Aventis USA, talks about the company's Auvi-Q injection system for the emergency treatment of life-threatening allergic reactions. Auvi-Q is the first and only compact epinephrine auto-injector with audio and visual cues that guide patients and caregivers through the injection process. Chew speaks with Dominic Chu on Bloomberg Television's "Bottom Line." Mark Crumpton also speaks. (Source: Bloomberg)
Is Virtual Reality the Next Mega-Trend in Tech?
30:24 - Piper Jaffray's Gene Munster and Canaan Partners' Maha Ibrahim discuss the future of virtual reality with Bloomberg Businessweek's Brad Stone on "Bloomberg West." (Source: Bloomberg)
  • Tech, Financials to Be Rediscovered in 2-3 Years: Lee
  • Week in Review: U.S. GDP Shrinks 0.7% in 1Q
  • Humana Soars as Possible Sale Explored